Trial intelligence / Profile preview

Remimazolam versus propofol for general anesthesia in urinary lithiasis surgery

ChiCTR2300077545Phase 4Not yet recruiting

Sponsor
Second Affiliated Hospital of Kunming Medical University
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of remimazolam and propofol in Lithiasis (2 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoints: mean blood pressure, heart rate and 4 more. Planned start Nov 2023; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

Lithiasis

Beyond the preview

Go deeper on ChiCTR2300077545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call